Ryan Zimmerman
Stock Analyst at BTIG
(4.19)
# 476
Out of 5,124 analysts
224
Total ratings
56.84%
Success rate
12.04%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Reiterates: Buy | $9 | $5.18 | +73.75% | 10 | Dec 26, 2025 | |
| CARL Carlsmed | Reiterates: Buy | $24 | $12.35 | +94.33% | 2 | Dec 15, 2025 | |
| RBOT Vicarious Surgical | Suspends: Neutral | n/a | $2.17 | - | 4 | Dec 12, 2025 | |
| SOLV Solventum | Upgrades: Buy | $100 | $79.24 | +26.20% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $78.81 | +15.47% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $0.96 | +524.67% | 6 | Nov 21, 2025 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $87 | $82.02 | +6.07% | 4 | Nov 21, 2025 | |
| RCEL AVITA Medical | Upgrades: Neutral | n/a | $3.45 | - | 4 | Nov 20, 2025 | |
| SYK Stryker | Reiterates: Buy | $410 | $351.47 | +16.65% | 18 | Nov 14, 2025 | |
| MDAI Spectral AI | Maintains: Buy | $3.5 → $3 | $1.42 | +111.27% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.78 | +91.33% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.46 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $112 | $89.92 | +24.56% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $29.00 | -3.45% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $116 | $112.91 | +2.74% | 14 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $17.79 | +29.29% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $310.91 | +2.92% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $529 → $589 | $566.36 | +4.00% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.49 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $177.44 | +9.90% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.01 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $31.46 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $14.30 | +60.84% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $125.29 | +18.13% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.42 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.31 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $12.42 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $23.09 | +129.54% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.16 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $130.12 | +53.70% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $284.24 | +23.14% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $96.06 | +33.25% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.63 | +28.98% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.46 | +127.52% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.49 | +1,070.57% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.73 | - | 3 | Apr 2, 2020 |
Organogenesis Holdings
Dec 26, 2025
Reiterates: Buy
Price Target: $9
Current: $5.18
Upside: +73.75%
Carlsmed
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $12.35
Upside: +94.33%
Vicarious Surgical
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.17
Upside: -
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $79.24
Upside: +26.20%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $78.81
Upside: +15.47%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $0.96
Upside: +524.67%
GE HealthCare Technologies
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $82.02
Upside: +6.07%
AVITA Medical
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.45
Upside: -
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $351.47
Upside: +16.65%
Spectral AI
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.42
Upside: +111.27%
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.78
Upside: +91.33%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Nov 5, 2025
Maintains: Buy
Price Target: $122 → $112
Current: $89.92
Upside: +24.56%
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $29.00
Upside: -3.45%
Oct 30, 2025
Maintains: Buy
Price Target: $104 → $116
Current: $112.91
Upside: +2.74%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $17.79
Upside: +29.29%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $310.91
Upside: +2.92%
Oct 22, 2025
Maintains: Buy
Price Target: $529 → $589
Current: $566.36
Upside: +4.00%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.49
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $177.44
Upside: +9.90%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $36.01
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $31.46
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.30
Upside: +60.84%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $125.29
Upside: +18.13%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.42
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.31
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.42
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $23.09
Upside: +129.54%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.16
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $130.12
Upside: +53.70%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $284.24
Upside: +23.14%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $96.06
Upside: +33.25%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.63
Upside: +28.98%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.46
Upside: +127.52%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.49
Upside: +1,070.57%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $32.73
Upside: -